Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell - this is where CST comes in.
We give everyday traders the opportunity to look over the shoulder of an equities analyst with a passion for the cannabis sector.
Members of CST get daily analysis and access to a model portfolio so they can review cannabis investments like a pro.
Leading The Way
Michael Vodicka is a globally syndicated equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
Joe Biden has been sworn in as the 46th President of the United States. There are few groups more excited than cannabis investors. The Joe Biden presidency is likely to fuel even better growth in the U.S. cannabis industry.
While I expect many cannabis stocks to benefit, I believe that one is in the best position to benefit from a cannabis-friendly administration.
When a stock jumps 124% in three weeks, it’s time to pay attention.
That’s what just happened to Liberty Health Sciences (CSE: LHS, OTC: LHSIF), one of the biggest players in Florida’s high-growth medical cannabis market, after the company announced it was being bought by a competitor. Continue “The Next Big Cannabis Buyout Target”
2020 turned out to be an incredible year for cannabis stocks.
After falling sharply in 2019, the sector was hit hard again in the spring when COVID-19 ravaged global markets. Cannabis stocks and sentiment hit a multi-year low, and many cannabis investors threw in the towel.
